Evidence map›Paper›PMID 38245675›Full record

ArticleBMC microbiology2024

Insights into estrogen impact in oral health & microbiome in COVID-19.

Rubén Alberto Bayardo-González, Marcela Peña-Rodríguez, Ana Laura Pereira-Suárez, Alina Xcaret Rubio-Sánchez, Mariel García-Chagollán, Daniel Natividad Valenzuela-Orozco, Melida Del Rosario Lizarazo-Taborda, Jesús Mora-Mora, Natali Vega-Magaña

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rubén Alberto Bayardo-GonzálezPrograma de Doctorado en Microbiología Médica, Centro Universitario de Ciencias de La Salud (CUCS) Universidad de Guadalajara, Guadalajara, Jalisco, México.
Marcela Peña-RodríguezLaboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes (LaDEER), CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, México.
Ana Laura Pereira-SuárezInstituto de Investigación en Ciencias Biomédicas (IICB), CUCS, Universidad de Guadalajara, Sierra Mojada 950, Colonia Independencia Oriente, Guadalajara, Jalisco, CP. 44340, México.
Alina Xcaret Rubio-SánchezPrograma de Maestría en Microbiología Médica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, México.
Mariel García-ChagollánInstituto de Investigación en Ciencias Biomédicas (IICB), CUCS, Universidad de Guadalajara, Sierra Mojada 950, Colonia Independencia Oriente, Guadalajara, Jalisco, CP. 44340, México.
Daniel Natividad Valenzuela-OrozcoPrograma de Licenciatura en Cirujano Dentista, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, México.
Melida Del Rosario Lizarazo-TabordaPrograma de Maestría en Microbiología Médica, CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, México.
Jesús Mora-MoraLaboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes (LaDEER), CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, México.
Natali Vega-MagañaLaboratorio de Diagnóstico de Enfermedades Emergentes y Reemergentes (LaDEER), CUCS, Universidad de Guadalajara, Guadalajara, Jalisco, México. alejandra.vega@academicos.udg.mx.
Universidad de Guadalajara · MX

Funding

Universidad de Guadalajara 265214 and 254496
6 · The paper itself

Abstract

backgroundCOVID-19 emerged in late 2019 and has occasioned more than 765 millions cumulative cases and 6.9 millions of deaths globally. Notably, around 70% of patients with severe COVID-19 are men. Therefore, it is to be presumed that women have a hormonal protector factor in inflammation and ACE2 expression. On the other hand, oral health status, and local microbiome can be key factors to respiratory viral infections control. Nevertheless, it has been poorly investigated. In our study 20 premenopausal, 18 postmenopausal and 22 men with COVID-19 were included. Oral health status, viral load, lingual ACE2 expression, as well as microbiome, estrogens and cytokines in saliva were analyzed.

resultsOur results showed a lower expression of ACE2 in tongue cells of postmenopausal compared with premenopausal (p = 0.05), and a strong negative correlation between saliva estrogen and viral load (r = -0.76; p = 0.001). Respect to IFN-γ (p = 0.05), IL-1β, TNF-α, IL-18, and IL-23 levels were increased in postmenopausal. Oral microbiome signature of premenopausal was characterized by Prevotella melaninogenica (Log2 = 26.68; p = 1.34e-10), Haemophilus (Log2 = 23.99; p = 2.96e-9), and Alloprevotella (Log2 = 7.92; p = 0.0001). On the other hand, Leptotrichia (Log2 = -18.74; p = 0.001), Tanerella (Log2 = -17.08; p = 0.004), and Clostridiales (Log2 = -2.88; p = 0.04) represented the poor oral health group compared with the adequate group which was enriched with the commensal microorganism Neisseria perflava (Log2 = 26.70; p = 1.74e-7). Furthermore, the high viral load group was characterized by Prevotella nanceiensis (Log2 = 19.60; p = 6.06e-8), Prevotella melaninogenica (Log2 = 21.45; p = 9.59e-6), Alloprevotella (Log2 = 23.50; p = 2.70e-7) and bacteria from the red complex Porphyromonas endodentalis (Log2 = 21.97; p = 1.38e-7).

conclusionsPostmenopausal and men have a poor oral health status which could be related to a detrimental progression of COVID-19 also linked to a lower expression of ACE2, lower saliva estrogen levels and oral dysbiosis. Nevertheless, functional studies are required for a deeper knowledge.

Indexed as

COVID-19MicrobiotaAngiotensin-Converting Enzyme 2BacteroidetesEstrogensFemaleHumansMaleOral HealthAngiotensin-Converting Enzyme 2EstrogensCOVID-19CytokinesInflammationMicrobiomeWomen-s health

Identifiers

PMID38245675
PMCPMC10799413
OpenAlexW4391051602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.